X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-12-04 | PBYI | Wong Alvin F | Chief Scientific Officer | S - Sale | $3.76 | -280 | 97,934 | 0% | -$1,053 | ||||||
2024-01-03 | PBYI | Wong Alvin F | Chief Scientific Officer | S - Sale | $4.49 | -7,733 | 98,214 | -7% | -$34,689 | ||||||
2024-01-03 | PBYI | Ludwig Jeffrey Jerome | Chief Commercial Officer | S - Sale | $4.49 | -12,956 | 99,970 | -11% | -$58,119 | ||||||
2024-01-03 | PBYI | Auerbach Alan H | Pres, CEO, 10% | S - Sale | $4.49 | -41,396 | 6,936,947 | -1% | -$185,698 | ||||||
2024-01-03 | PBYI | Nougues Maximo F | CFO | S - Sale | $4.49 | -15,682 | 128,666 | -11% | -$70,348 | ||||||
2024-01-03 | PBYI | Hunt Douglas M | See Remarks | S - Sale | $4.49 | -8,358 | 103,319 | -7% | -$37,493 | ||||||
2023-11-07 | PBYI | Miller Michael Patrick | Dir | S - Sale | $2.83 | -25,000 | 43,358 | -37% | -$70,803 | ||||||
2023-07-03 | PBYI | Wong Alvin F | Chief Scientific Officer | S - Sale | $3.31 | -6,938 | 105,947 | -6% | -$22,973 | ||||||
2023-07-03 | PBYI | Nougues Maximo F | CFO | S - Sale | $3.31 | -14,680 | 144,348 | -9% | -$48,608 | ||||||
2023-07-03 | PBYI | Ludwig Jeffrey Jerome | Chief Commercial Officer | S - Sale | $3.31 | -12,103 | 112,926 | -10% | -$40,075 | ||||||
2023-07-03 | PBYI | Hunt Douglas M | See Remarks | S - Sale | $3.31 | -7,809 | 111,677 | -7% | -$25,857 | ||||||
2023-07-03 | PBYI | Auerbach Alan H | Pres, CEO, 10% | S - Sale | $3.31 | -60,698 | 6,978,343 | -1% | -$200,983 | ||||||
2023-06-13 | PBYI | Wilson Troy Edward | Dir | S - Sale | $3.45 | -27,000 | 27,900 | -49% | -$93,269 | ||||||
2023-06-13 | PBYI | Moyes Jay M | Dir | S - Sale | $3.45 | -22,000 | 43,322 | -34% | -$75,970 | ||||||
2023-06-13 | PBYI | Stuglik Brian M | Dir | S - Sale | $3.46 | -9,900 | 58,958 | -14% | -$34,252 | ||||||
2023-06-13 | PBYI | Senderowicz Adrian | Dir | S - Sale | $3.45 | -27,000 | 27,000 | -50% | -$93,280 | ||||||
2023-06-13 | PBYI | Dorval Allison | Dir | S - Sale | $3.45 | -10,000 | 44,000 | -19% | -$34,500 | ||||||
2023-06-13 | PBYI | Miller Michael Patrick | Dir | S - Sale | $3.45 | -13,500 | 68,358 | -16% | -$46,630 | ||||||
2023-06-02 | PBYI | Wong Alvin F | Chief Scientific Officer | S - Sale | $3.45 | -269 | 112,885 | 0% | -$928 | ||||||
2023-01-03 | PBYI | Wong Alvin F | Chief Scientific Officer | S - Sale | $4.18 | -3,460 | 54,553 | -6% | -$14,456 | ||||||
2023-01-03 | PBYI | Nougues Maximo F | CFO | S - Sale | $4.18 | -10,499 | 100,427 | -9% | -$43,864 | ||||||
2023-01-03 | PBYI | Ludwig Jeffrey Jerome | Chief Commercial Officer | S - Sale | $4.18 | -6,568 | 58,057 | -10% | -$27,440 | ||||||
2023-01-03 | PBYI | Hunt Douglas M | See Remarks | S - Sale | $4.18 | -4,225 | 71,350 | -6% | -$17,652 | ||||||
2023-01-03 | PBYI | Auerbach Alan H | Pres, CEO, 10% | S - Sale | $4.18 | -27,241 | 6,852,638 | 0% | -$113,810 | ||||||
2022-12-02 | PBYI | Auerbach Alan H | Pres, CEO, 10% | S - Sale | $4.50 | -1,251 | 6,311,698 | 0% | -$5,627 | ||||||
2022-12-02 | PBYI | Hunt Douglas M | See Remarks | S - Sale | $4.50 | -429 | 75,575 | -1% | -$1,930 | ||||||
2022-12-02 | PBYI | Nougues Maximo F | CFO | S - Sale | $4.50 | -159 | 110,926 | 0% | -$715 | ||||||
2022-12-02 | PBYI | Wong Alvin F | Chief Scientific Officer | S - Sale | $4.50 | -514 | 58,013 | -1% | -$2,312 | ||||||
2022-11-02 | PBYI | Hunt Douglas M | See Remarks | S - Sale | $2.25 | -429 | 76,004 | -1% | -$965 | ||||||
2022-11-02 | PBYI | Auerbach Alan H | Pres, CEO, 10% | S - Sale | $2.25 | -1,242 | 6,312,949 | 0% | -$2,795 | ||||||
2022-11-02 | PBYI | Nougues Maximo F | CFO | S - Sale | $2.25 | -163 | 111,085 | 0% | -$367 | ||||||
2022-10-03 | PBYI | Nougues Maximo F | CFO | S - Sale | $2.34 | -165 | 111,248 | 0% | -$385 | ||||||
2022-10-03 | PBYI | Hunt Douglas M | See Remarks | S - Sale | $2.34 | -435 | 76,433 | -1% | -$1,016 | ||||||
2022-10-03 | PBYI | Auerbach Alan H | Pres, CEO, 10% | S - Sale | $2.34 | -1,260 | 6,314,191 | 0% | -$2,943 | ||||||
2022-09-02 | PBYI | Nougues Maximo F | CFO | S - Sale | $2.59 | -164 | 111,413 | 0% | -$425 | ||||||
2022-09-02 | PBYI | Hunt Douglas M | See Remarks | S - Sale | $2.59 | -433 | 76,868 | -1% | -$1,121 | ||||||
2022-09-02 | PBYI | Auerbach Alan H | Pres, CEO, 10% | S - Sale | $2.59 | -1,254 | 6,315,451 | 0% | -$3,247 | ||||||
2022-08-09 | PBYI | Miller Michael Patrick | Dir | S - Sale | $3.55 | -25,000 | 54,858 | -31% | -$88,793 | ||||||
2022-08-02 | PBYI | Nougues Maximo F | CFO | S - Sale | $2.89 | -161 | 111,577 | 0% | -$465 | ||||||
A | 2022-07-05 | PBYI | Nougues Maximo F | CFO | S - Sale | $2.63 | -9,328 | 111,738 | -8% | -$24,547 | |||||
2022-08-02 | PBYI | Hunt Douglas M | See Remarks | S - Sale | $2.89 | -429 | 77,301 | -1% | -$1,240 | ||||||
2022-08-02 | PBYI | Auerbach Alan H | Pres, CEO, 10% | S - Sale | $2.89 | -1,247 | 6,316,705 | 0% | -$3,604 | ||||||
2022-07-05 | PBYI | Hunt Douglas M | See Remarks | S - Sale | $2.63 | -3,753 | 77,730 | -5% | -$9,876 | ||||||
2022-07-05 | PBYI | Auerbach Alan H | Pres, CEO, 10% | S - Sale | $2.63 | -26,140 | 6,317,952 | 0% | -$68,787 | ||||||
2022-07-05 | PBYI | Nougues Maximo F | CFO | S - Sale | $2.63 | -5,835 | 64,625 | -8% | -$15,355 | ||||||
2022-07-05 | PBYI | Ludwig Jeffrey Jerome | Chief Commercial Officer | S - Sale | $2.63 | -5,835 | 64,625 | -8% | -$15,355 | ||||||
2022-07-05 | PBYI | Wong Alvin F | Chief Scientific Officer | S - Sale | $2.63 | -2,920 | 58,527 | -5% | -$7,684 | ||||||
2022-06-16 | PBYI | Senderowicz Adrian | Dir | S - Sale | $2.63 | -27,858 | 27,000 | -51% | -$73,303 | ||||||
2022-06-16 | PBYI | Wilson Troy Edward | Dir | S - Sale | $2.58 | -27,858 | 27,900 | -50% | -$71,971 | ||||||
2022-06-16 | PBYI | Stuglik Brian M | Dir | S - Sale | $2.69 | -13,000 | 41,858 | -24% | -$34,918 | ||||||
2022-06-16 | PBYI | Moyes Jay M | Dir | S - Sale | $2.64 | -22,858 | 38,322 | -37% | -$60,370 | ||||||
2022-06-02 | PBYI | Wong Alvin F | Chief Scientific Officer | S - Sale | $1.92 | -587 | 61,447 | -1% | -$1,129 | ||||||
2022-06-02 | PBYI | Nougues Maximo F | CFO | S - Sale | $1.92 | -162 | 121,066 | 0% | -$311 | ||||||
2022-06-02 | PBYI | Hunt Douglas M | See Remarks | S - Sale | $1.94 | -417 | 81,483 | -1% | -$811 | ||||||
2022-06-02 | PBYI | Auerbach Alan H | Pres, CEO, 10% | S - Sale | $1.94 | -1,200 | 6,344,092 | 0% | -$2,333 | ||||||
2022-05-03 | PBYI | Hunt Douglas M | See Remarks | S - Sale | $2.31 | -438 | 81,900 | -1% | -$1,012 | ||||||
2022-05-03 | PBYI | Nougues Maximo F | CFO | S - Sale | $2.34 | -165 | 121,228 | 0% | -$386 | ||||||
2022-05-03 | PBYI | Nougues Maximo F | CFO | S - Sale | $2.34 | -165 | 121,228 | 0% | -$386 | ||||||
2022-05-03 | PBYI | Nougues Maximo F | CFO | S - Sale | $2.34 | -165 | 121,228 | 0% | -$386 | ||||||
2022-05-03 | PBYI | Auerbach Alan H | Pres, CEO, 10% | S - Sale | $2.32 | -1,263 | 6,345,292 | 0% | -$2,930 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |